Authors: Nguyen, CL Bui, JT Demcheva, M Vournakis, JN Cole, DJ Gillanders, WE

Citation: Cl. Nguyen et al., Sustained release of granulocyte-macrophage colony-stimulating factor froma modular peptide-based cancer vaccine alters vaccine microenvironment andenhances the antigen-specific T-cell response, J IMMUNOTH, 24(5), 2001, pp. 420-429

Authors: Chan, MW Schwaitzberg, SD Demcheva, M Vournakis, J Finkielsztein, S Connolly, RJ

Citation: Mw. Chan et al., Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage, J TRAUMA, 48(3), 2000, pp. 454-457

Authors: Maitre, N Brown, JM Demcheva, M Kelley, JR Lockett, MA Vournakis, J Cole, DJ

Citation: N. Maitre et al., Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination, CLIN CANC R, 5(5), 1999, pp. 1173-1182

Authors: Cole, DJ Connolly, RJ Chan, MW Schwaitzberg, SD Byrne, TK Adams, DB Baron, PL O'Brien, PH Metcalf, JS Demcheva, M Vournakis, J

Citation: Dj. Cole et al., A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent, SURGERY, 126(3), 1999, pp. 510-517